Stanford researchers have used deep learning to create a radiotherapy treatment plan verification algorithm. Patient specific dose verification is traditionally done by checking the dose in a patient-mimicking phantom or by using an independent dose calculation algorithm.
Researchers at Stanford and the Chan Zuckerberg Biohub have discovered cross reactive, broadly neutralizing human antibodies against all serotypes of dengue virus.
Engineered cytotoxic T cells are a promising class of cell therapies. These living drugs are capable of selectively killing blood cancers, such as acute myeloid leukemia (AML), and delaying its progression.
Stanford researchers have shown how to use fluorescent and phosphorescent materials to provide plants with photons in the photosynthetically active radiation (PAR) range for increased crop yields and CO2 fixation.
Ear infections are a serious condition, especially in children, and represent a $4B market. Otitis media (OM) is when the middle ear becomes inflamed and affects 90% of children worldwide.
Researchers at Stanford University have designed a scalable photonic quantum computer which does not require single-photon detectors and which uses minimal quantum resources: one coherently controlled atom.
Researchers from the Bent group have identified a new precursor and small molecule inhibitor combination for Al2O3 area-selective atomic layer deposition (ALD).
Researchers at Stanford have developed chemically defined, polyvinyl alcohol (PVA)-based media for culturing hematopoietic stem cells and immune cells (e.g., T cells).
Volumetric contrast-enhanced ultrasound is a new approach to collect 3D imaging data of a contrast signal. So far, analysis of 3D contrast ultrasound has relied on averaging a set of voxels embedded in an ROI or a VOI.
Researchers at Stanford have developed synthetic derivatives of a natural product, azapodophyllotoxin (AZP), that exhibit remarkable anticancer activities.